Profile of Crizanlizumab and Its Potential in the Prevention of Pain Crises in Sickle Cell Disease: Evidence to Date

Journal of Blood Medicine - New Zealand
doi 10.2147/jbm.s191423
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Informa UK Limited

Related search

Profile of Buparlisib and Its Potential in the Treatment of Breast Cancer: Evidence to Date [Corrigendum]

Breast Cancer: Targets and Therapy
Oncology
2018English

APS Sickle Cell Disease Conference Mini-Review: Targeting Pain at Its Source in Sickle Cell Disease

American Journal of Physiology - Regulatory Integrative and Comparative Physiology
Physiology
2018English

Acute Chest Pain in Sickle Cell Disease- Its Unusual Cause

Journal of Blood Disorders & Transfusion
2015English

Characterization of Neuropathic Pain in Sickle Cell Disease

West Indian Medical Journal
Medicine
2017English

Evidence to Date: Ranibizumab and Its Potential in the Treatment of Retinopathy of Prematurity

Eye and Brain
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2019English

Managing Leg Ulcer Pain in Sickle Cell Disease

Revista Brasileira de Hematologia e Hemoterapia
2010English

A Phase 1 Dose-Finding Study of Intravenous L-Citrulline in Sickle Cell Disease: A Potential Novel Therapy for Sickle Cell Pain Crisis

British Journal of Haematology
Hematology
2018English

Transfusion and Alloimmunization in Sickle Cell Disease. The Cooperative Study of Sickle Cell Disease

Blood
BiochemistryImmunologyCell BiologyHematology
1990English

Sleep Disturbance, Depression and Pain in Adults With Sickle Cell Disease

BMC Psychiatry
PsychiatryMental Health
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy